PRESS RELEASES More events are coming soon. Keyword Search Year: 20232022202120202019201820172016201520142013 10/12/06 Summary Toggle Case Licenses Methoxyamine to Tracon Printer Friendly Release59f0f14a-c2a8-4415-b769-1b629c275c5a_2010121.pdf 14.7 KB 08/02/06 Summary Toggle Tracon Pharmaceuticals appoints Charles P.Theuer, M.D., Ph.D as President and Chief Executive Officer Printer Friendly Release4158c9c2-d21b-4a4a-a11a-73b709a9bca5_2010122.pdf 8.4 KB 03/14/06 Summary Toggle TRACON Pharmaceuticals assembles industry-leading management team to support development of targeted cancer therapy pipeline Printer Friendly Release838f81f6-771f-40b6-99e9-8be67b7a48db_2010123.pdf 17.6 KB 04/16/05 Summary Toggle Lexington Pharmaceuticals changes name to TRACON Pharmaceuticals, Inc. Lexington Pharmaceuticals announced that it has changed its name to TRACON Pharmaceuticals, Inc., and has moved the company from New York, New York to San Diego, California. Printer Friendly Releasefa84284c-e508-4765-90ce-d3ad5de2a7cf_2010130.pdf 6.1 KB 04/01/05 Summary Toggle Lexington Pharmaceuticals names Bert Liang, MD MBA as President and CEO. Dr. Liang was formerly Vice President of New Ventures, at Biogen Idec. Printer Friendly Release64aedcd4-e4e8-47eb-b2c1-fb488d84bb47_2010131.pdf 5.4 KB Pagination First page First Previous page Previous … Page 27 Page 28 Page 29 Current page 30
